M. I. Ikhile et al.
Synthesis of 1-(ferrocenylmethylene)imidazole (2)
(s, 1H, CH), 7.03 (m, 2H, NCH, NCH), 5.36 (s, 2H, NCH2), 4.41
(s, 2H, C5H4), 4.26 (m, 9H, C5H4, C5H5, NCH2), 1.87 (m, 2H, CH2),
1.36 (m, 2H, CH2), 0.95 (t, J 7.2, 3H, CH3); 13C NMR (100 MHz,
CDCl3), 136.42 (imd-C), 120.80 (NCH), 120.66 (NCH), 78.83, 77.33,
69.84, 69.56, 69.30 (ferrocenyl moiety), 49.98 (NCH2), 32.12
(CH2), 19.53 (CH2), 13.44 (CH3); m/z (ESI): 199 (M+ ꢀ imd ꢀ Br-,
6%), 323 (M+ ꢀ Br- , 100%), 324 (M+ ꢀ Br- + 1, 22%); Anal. calcd
for C18H23N2FeBr 323.12107 (M+ ꢀ Brꢀ); found 323.12104
(M+ ꢀ Br-).
Ferrocenylmethanol, 1 (0.5 g, 2.3 mmol) and an excess of N,N0-
carbonyldiimidazole (0.52 g, 3.2 mmol) were dissolved in a mini-
mum of amount DCM (10 ml). The mixture was brought to reflux
and the temperature maintained at 45 ꢁC. TLC was used to mon-
itor the reaction, which was completed after 1 h. The reaction was
quenched and allowed to cool to room temperature. Diethyl
ether (30 ml) was then added to the product mixture, which
was stirred for 5 min at room temperature. Solvent was removed
in vacuo and the resulting product was subjected to column
chromatography on silica gel. Diethyl ether was used to flash
down any unreacted starting material. Ethyl acetate (100%) was
later used to obtain the product, as yellow powder. Yield 0.32 g,
53%; m.p. 80 ꢁC; IR (ATR cmꢀ1) 3392, 3117, 1638, 1509, 1437,
1237, 1218, 1102, 1077, 809, 740, 658, 479; 1H NMR (400 MHz,
CDCl3): d 7.46 (s, 1H, CH), 7.00 (s, 1H, NCH), 6.89 (s, 1H, NCH),
4.84 (s, 2H, CH2), 4.16 (m, 9H, C5H4, C5H5); 13C NMR (100 MHz,
CDCl3): d 136.47 (imd-C), 129.00 (NCH), 118.60 (NCH), 82.51,
68.58, 68.31 (ferrocenyl moiety), 46.52 (CH2); m/z (ESI): 199
(M+ ꢀ imd [imd = imidazole], 6%), 267 (M+ , 100%), 268 (M+ + 1,
18%). Anal. calcd for C14H14N2Fe 267.05847 (M+); found
267.05748 (M+).
Synthesis of 1-(4-ferrocenylphenyl)imidazole (6)
A solution of sodium nitrite (0.088 g, 1.26mmol) in water (2ml) was
added dropwise to an ice-cold solution of 4-(1H-imidazol-1-yl)
aniline (0.2 g, 1.26 mmol) and aqueous tetrafluoroboric acid (50%,
0.4 ml, 6.2 mmol) in water (4ml), whereupon a yellowish precipi-
tate was observed. After complete addition of the sodium nitrite
solution, the mixture was stirred for another 5 min, followed by
the dropwise addition of a solution of ferrocene (0.24 g, 1.26 mmol)
prepared from a mixture of CH3CN and CH2Cl2 (1:2) 3 ml, resulting
in a greenish-brown suspension. The cooling bath was removed
and the mixture was further stirred for 1 h. Subsequently, H2O
(40 cm3) was added and the reaction mixture extracted with
CH2Cl2 (2ꢂ 14ml). The red organic layer was washed with dilute
Na2SO4; the solvent was removed in vacuo, resulting in a brown
residue, which was washed with n-hexane (3ꢂ 6 cm3) to remove
residual ferrocene. A brownish-orange powder was obtained. Yield
0.12 g, 30%; m.p. 161.5ꢁC; IR (ATR cmꢀ1) 3096, 1660, 1531, 1488,
1302, 1249, 1103, 1055, 1031, 1002, 885, 813, 725, 655, 531, 509,
Synthesis of 1-(ferrocenylmethylene)-3-methylimidazolium iodide (3)
In a two-necked flask, methyl iodide (0.3 ml, 8.1 mmol) was added
to ferrocenylmethylene imidazole (0.05 g, 0.19 mmol) and was
allowed to reflux gently at 50 ꢁC under an atmosphere of nitrogen
for 15 h. The mixture was then allowed to cool to room tempera-
ture, washed with anhydrous diethyl ether (5 ꢂ 3 ml) until diethyl
ether remained clear after washing. A yellow powder was
obtained. Yield 0.056 g, 72%; m.p. 145.5 ꢁC; IR (ATR cmꢀ1) 3173,
1566, 1331, 1243, 1331, 1174, 1150, 811, 754, 710, 619, 553, 480;
1H NMR (400 MHz, CDCl3): d 9.92 (s, 1H, CH), 7.28 (s, 1H, NCH),
7.26 (s, 1H, NCH), 5.34 (s, 2H, CH2), 4.47 (s, 2H, C5H4), 4.26
(m, 7H, C5H4, C5H5), 4.04 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3):
d 135.96 (imd-C), 123.27 (NCH), 121.55 (NCH), 78.46, 77.30,
69.86, 69.70, 69.24 (ferrocenyl moiety), 50.05 (NCH3); m/z (ESI):
199 (M+ ꢀ imd ꢀ Iꢀ, 6%), 281 (M+ ꢀ Iꢀ , 100%), 282 (M+ ꢀ Iꢀ + 1,
18%). Anal. calcd for C15H17N2FeI 281.07412 (M+ ꢀ Iꢀ); found
281.07350 (M+ ꢀ Iꢀ).
1
482, 456; H NMR (400 MHz, CDCl3) d 7.85 (s, 1H, CH), 7.54 (d, J
8.4, 2H, C6H4), 7.29 (m, 3H, C6H4, NCH), 7.19 (s, 1H, NCH), 4.64 (t, J
1.6, 2H, C5H4), 4.35 (t, J 1.6, 2H, C5H4), 4.04 (s, 5H, C5H5), 13C NMR
(100MHz, CDCl3) d 139.24 (imd-C), 135.57 (Ar-C), 135.10 (Ar-C),
130.35 (Ar-CH), 127.24 (Ar-CH), 121.57 (NCH), 118.24 (NCH), 83.88,
69.73, 69.38, 66.95 (ferrocenyl moiety); m/z (ESI): 262 (M+ ꢀ imd,
17%), 329 (M+ , 100%), 330 (M+ + 1, 22%); Anal. calcd for
C19H16N2Fe 329.07412 (M+); found 329.07411 (M+).
General Procedure for the Preparation of Compounds 7–9
In a two-neck flask, 1-(4-ferrocenylphenyl) imidazole (1 molar
equiv.) was reacted with the respective alkylhalide (5 molar
equiv.) in CH2Cl2 (15 ml). The mixture was stirred for 41 h at room
temperature. After solvent removal, the mixture was treated with
Et2O (10 cm3), filtered, washed with Et2O (3 ꢂ 15 ml) and dried
in vacuo. Crystals suitable for X-ray analysis were obtained by
slow diffusion of hexane into a CH2Cl2 solution.
Synthesis of 1-(ferrocenylmethylene)-3-ethylimidazolium bromide (4)
Synthesis similar to 3 using ethyl bromide (0.6 ml, 8.1 mmol), to
give a yellow powder. Yield 0.06 g, 84%; m.p. 92.3 ꢁC; IR (ATR
cmꢀ1) 3432, 3386, 3138, 3065, 2065, 1626, 1565, 1558, 1463,
1412, 1347, 1319, 1236, 1157, 1027, 1007, 848, 807, 774, 708,
554, 506, 485, 447; 1H NMR (400 MHz, CDCl3): d 10.62 (s, 1H,
CH), 7.16 (s, 1H, NCH), 7.11 (s, 1H, NCH), 5.34 (s, 2H, CH2), 4.42
(s, 2H, C5H4), 4.36 (q, J 7.3, 2H, NCH2,), 4.23 (s, 7H, C5H4, C5H5),
1.56 (t, J 7.3, 3H, CH3); 13C NMR (100 MHz, CDCl3) d 136.94
(imd-C), 120.18 (NCH), 120.99 (NCH), 77.58, 70.09, 69.85, 69.54,
50.16 (ferrocenyl moiety), 45.56 (NCH2), 15.76 (CH3); m/z (ESI):
199 (M+ ꢀ imd ꢀ Brꢀ, 6%), 295 (M+ ꢀ Br- , 100%), 296 (M+ ꢀ Br- + 1,
18%). Anal. calcd for C16H19N2FeBr 295.08977 (M+ ꢀ Brꢀ); found
295.08962 (M+ ꢀ Brꢀ).
Synthesis of 1-(4-ferrocenylphenyl)-3-methylimidazolium iodide (7)
This compound was prepared from 1-(4-ferrocenylphenyl)imidazole
(0.1 g, 0.3 mmol) and methyl iodide (0.1 ml, 1.5 mmol). The crude
product was obtained as an orange powder. Yield 0.12 g, 86%;
m.p. 140.5 ꢁC; IR (ATR cmꢀ1) 3396, 3079, 1552, 1528, 1220, 1071,
1
820, 749, 620, 542, 504, 459; H NMR (400 MHz, CDCl3) d 10.65
(s, 1H, CH), 7.64 (m, 4H, C6H4), 7.52 (s, 1H, NCH), 7.40 (s, 1H,
NCH), 4.66 (t, J 1.7, 2H, C5H4), 4.39 (t, J 1.7, 2H, C5H4), 4.27 (s, 3H,
NCH3), 4.04 (s, 5H, C5H5); 13C NMR (100 MHz, CDCl3) d 143.15
(imd-C), 135.93 (Ar-C), 131.59 (Ar-C), 127.67 (Ar-CH), 123.99
(Ar-CH), 122.04 (NCH), 120.37 (NCH), 82.37, 69.88, 67.89, 66.79
(ferrocenyl moiety), 37.63 (NCH3); m/z (ESI): 262 (M+ ꢀ imd ꢀ Iꢀ,
7%), 343 (M+ ꢀ Iꢀ , 100%), 344 (M+ ꢀ Iꢀ + 1, 22%); Anal. calcd for
C20H19N2FeI 343.08977 (M+ ꢀ Iꢀ); found 343.08906 (M+ ꢀ Iꢀ).
Synthesis of 1-(ferrocenylmethylene)-3-butylimidazolium bromide (5)
Synthesis similar to 3 using butyl bromide (2.6 ml, 8.1 mmol). A
dark-brown powder was obtained. Yield 0.07 g, 92%; m.p.
85.5 ꢁC; IR (ATR cmꢀ1) 3571, 3393, 3168, 2965, 1563, 1448, 1155,
1
1105, 812, 656, 631, 553, 478; H NMR (400 MHz, CDCl3) d 10.78
wileyonlinelibrary.com/journal/aoc
Copyright © 2013 John Wiley & Sons, Ltd.
Appl. Organometal. Chem. 2013, 27, 98–108